Clinical Cancer Therapy and Prevention Research

Program Announcement:
PA-04-046: http://grants.nih.gov/grants/guide/pa-files/PA-04-046.html (expiration date extended to 11/2/2006)

Contacts:
Keyvan Farahani, Ph.D.—imaging
301-451-2651, farahank@mail.nih.gov

Roy Wu, Ph.D.—clinical grants & contracts
301-496-8866,

CIP supports translational clinical studies and encourages investigators to conduct trials that will move discoveries and advances in basic biology and drug development to the patient’s bedside. This initiative, which supports R01 grants to individual investigators for up to five years, encompasses a full range of therapeutic and preventive studies that employ single therapies as well as combinations that can include conventional (drugs, radiation, surgery) or unconventional (dietary supplements, bioactive food components, hypothermia, and hyperthermia) elements.

This initiative also supports programs in molecular profiling, as well as correlative studies that have been linked to therapeutic and preventive trials.